Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-249346
Filing Date
2025-10-24
Accepted
2025-10-24 07:17:38
Documents
156
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 20-F d33851d20f.htm   iXBRL 20-F 3818985
2 EX-4.1 d33851dex41.htm EX-4.1 144557
3 EX-12.1 d33851dex121.htm EX-12.1 10255
4 EX-13.1 d33851dex131.htm EX-13.1 5122
5 EX-15.1 d33851dex151.htm EX-15.1 1463
7 GRAPHIC g33851g1007175555631.jpg GRAPHIC 110281
  Complete submission text file 0001193125-25-249346.txt   17967466

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA immp-20250630.xsd EX-101.SCH 2684924
158 EXTRACTED XBRL INSTANCE DOCUMENT d33851d20f_htm.xml XML 4228015
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-35428 | Film No.: 251414280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)